Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Indianapolis, Indiana


Safety and effectiveness of Natrelle™ Cohesive Round Silicone-Filled Breast Implants in women undergoing primary reconstruction or revision of existing breast implants.


Inclusion Criteria: - Females of any age for which breast reconstruction is considered appropriate (Patients under 18 years old require parental/legal guardian consent to participate. - Females seeking revision augmentation or revision reconstruction, where problems exist - Have any of the following conditions or situations present: - Post mastectomy surgical removal of the breast for cancer or other disease; - Post trauma or post surgery where there was total or partial removal of the breast resulting in significant deformity; - Severe ptosis requiring reconstruction; - Any congenital or acquired discrepancy in breast size such as to represent a significant physical deformity. - Adequate tissue available to cover implants. - Saline-filled implants are not an appropriate choice. Exclusion Criteria: - Advanced fibrocystic disease considered to be premalignant without accompanying subcutaneous mastectomy. - Existing carcinoma of the breast, without mastectomy. - Abscess of infection in the body at the time of enrollment. - Pregnant or nursing. - Have any disease, including uncontrolled diabetes, which is clinically known to impact wound healing ability. - Show tissue characteristics which are clinically incompatible with mammaplasty. - Have, or under treatment for any condition which, in the opinion of the surgeon, may constitute an unwarranted surgical risk. - Are not willing to undergo further surgery for revision, if medically required. - Diagnosis of lupus or scleroderma.

Study is Available At:

Original ID:




Secondary ID:

Study Acronym:

Brief Title:

Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

Official Title:

Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

Overall Status:


Study Phase:




Minimum Age:


Maximum Age:


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

Allergan Medical

Oversight Authority:

United States: Institutional Review Board

Reasons Why Stopped:

Study Type:


Study Design:

Allocation: Non-Randomized, Endpoint Classificati

Number of Arms:


Number of Groups:


Total Enrollment:


Enrollment Type:


Study Dates

Start Date:December 1997
Completion Date:December 2012
Completion Type:Actual
Primary Completion Date:December 2012
Primary Completion Type:Actual
Verification Date:June 2013
Last Changed Date:June 4, 2013
First Received Date:June 3, 2008

Study Outcomes

Outcome Type:Primary Outcome
Measure:Local complications
Time Frame:5 years
Safety Issues:True
Outcome Type:Secondary Outcome
Measure:Satisfaction determined by patients and physicians
Time Frame:5 years
Safety Issues:False

Study Interventions

Intervention Type:Device
Name:Natrelle(TM) Silicone-Filled Breast Implants
Description:Breast implant surgery
Arm Name:1

Study Arms

Study Arm Type:Experimental
Arm Name:1
Description:Primary reconstruction
Study Arm Type:Experimental
Arm Name:2
Study Arm Type:Experimental
Arm Name:3

Study Agencies

Agency Class:Industry
Agency Type:Lead Sponsor
Agency Name:Allergan Medical

Sample and Retention Information

There are no available Sample and Retention Information

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

This study is not currently recruiting Study Participants. The form below is not enabled.